Table 1 Study Population
Total | Men | Women | |
|---|---|---|---|
Type 1 Diabetes mellitus | 19 (32%) | 11 (35%) | 8 (29%) |
Type 2 Diabetes mellitus | 40 (68%) | 20 (65%) | 20 (71%) |
Age | 63.3 ± 1.7 | 63.5 ± 2.4 | 63 ± 2.6 |
Diabetes duration | 20.7 ± 1.4 | 20.4 ± 2.1 | 21 ± 1.7 |
Hypertension | 51 (86%) | 27 (87%) | 22 (79%) |
Systolic blood pressure | 135 ± 2 | 133 ± 3 | 137 ± 3 |
Diastolic blood pressure | 77 ± 1 | 76 ± 2 | 77 ± 2 |
Hyperlipoproteinemia | 39 (66%) | 19 (61%) | 20 (71%) |
Smoker | 4 (7%) | 3 (10%) | 1 (4%) |
BMI (kg/m 2 ) | 27.8 ± 0.6 | 27.3 ± 0.6 | 28.3 ± 1.2 |
Coronary heart disease | 22 (37%) | 15 (48%) | 7 (25%) |
Cerebrovascular disease | 11 (19%) | 8 (26%) | 3 (11%) |
Peripheral artery disease | 15 (25%) | 10 (32%) | 5 (18%) |
Insulintherapy | 51 (86%) | 25 (81%) | 26 (93%) |
Oral antidiabetic drugs | 21 (36%) | 11 (35%) | 10 (36%) |
ACEI/ARB | 43 (73%) | 23 (74%) | 20 (71%) |
Lipid lowering drugs | 36 (61%) | 19 (61%) | 17 (61%) |
HbA1c (%) | 7.3 ± 0.1 | 7.5 ± 0.2 | 7.1 ± 1.3 |
Creatinine (mg/dl) | 1.2 ± 0.2 | 1.3 ± 0.2 | 1.1 ± 0.2* |
LDL-Cholesterol (mg/dl) | 101.9 ± 3.7 | 102.4 ± 5.1 | 101.3 ± 5.6 |
HDL-Cholesterol (mg/dl) | 49.9 ± 1.9 | 47.2 ± 2.6 | 52.6 ± 2.8 |
Triglycerides (mg/dl) | 181.0 ± 16.5 | 168.3 ± 18.3 | 195.1 ± 29.0 |